Association between loss of hypercoagulable phenotype, clinical features and complement pathway consumption in COVID-19
Description
CONCLUSIONS: While hypercoagulable states become more evident with increasing severity of respiratory disease in patients with COVID-19, normocoagulable phenotype is associated with triggered by alternative pathway activation and poor outcomes.
